TRDA
Entrada Therapeutics, Inc. · Healthcare
MPM BIOVENTURES 2018, L.P. sold $617K of Entrada Therapeutics, Inc.
10% owner
Sold$617,379
$7.14Price
86,482Shares
−2%Stake
What TRDA did after the filing
- The stock from Fri, Sep 4 open, $7.11
- −32.2%
- S&P 500, same days
- −0.7%
Measured over 30 trading days, to the Oct 19 close.
Traded Tue, Sep 1. Filed Thu, Sep 3, 7:21 PM ET, after the close. Returns use the Sep 4 open and the Oct 19 close. Not investment advice.